Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2009
09/17/2009US20090235372 Hairless Immunodeficient Mouse Model
09/17/2009US20090235371 Diagnostic method
09/17/2009US20090235369 Transgenic Non-Human Animals Expressing Human Blood Clotting Factors and Uses Thereof
09/17/2009US20090235368 Transgenic animal models of disease
09/17/2009US20090235367 Non-human mammal comprising a modified SERCA2 gene and methods, cells, genes, and vectors thereof
09/17/2009US20090234103 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
09/17/2009US20090234101 Directed evolution of novel binding proteins
09/17/2009US20090233994 Novel Glutamic Acid Decarboxylase (GAD) Chimera And Methods Of Use
09/17/2009US20090233993 Compositions and methods for inhibiting gsk3 activity and uses thereof
09/17/2009US20090233992 Hepatitis c virus vaccine
09/17/2009US20090233991 Generation of biological pacemaker activity
09/17/2009US20090233990 Generation of biological pacemaker activity
09/17/2009US20090233989 Oligonucleotides stimulatory of the mesenchymal stem cell proliferation and uses thereof
09/17/2009US20090233988 Therapeutic Agents for Diseases Associated With Apoptotic Degeneration in Ocular Tissue Cells That Use SIV-PEDF Vectors
09/17/2009US20090233986 Methods and compositions for using sax2
09/17/2009US20090233985 Compositions and methods for inhibiting hiv infections by inhibiting lerepo4 and glipr
09/17/2009US20090233984 RNAi Modulation of RSV and Therapeutic Uses Thereof
09/17/2009US20090233983 RNA Interference Mediated Inhibition of Protein Tyrosine Phosphatase-1B (PTP-1B) Gene Expression Using Short Interfering RNA
09/17/2009US20090233982 Methyltransferases and Their Uses
09/17/2009US20090233981 Compounds for Hydrolyzing Ribonucleic Acids (RNA's)
09/17/2009US20090233868 Small antiviral peptides against hepatitis C virus
09/17/2009US20090233866 Screening Methods And The Use Of Agents Identified Using The Same
09/17/2009US20090233861 Lytic domain fusion constructs and methods of making and using same
09/17/2009US20090233860 Lytic domain fusion constructs and methods of making and using same
09/17/2009US20090233859 modulating hepcidin and disease of iron metabolism such as hemochromatosis and anemia of chronic disease; adminstering soluble mammalian hemojuvelin protein
09/17/2009US20090233857 Dna vaccine compositions and methods of use
09/17/2009US20090233855 Compounds and methods for modulating activation of nf-kb
09/17/2009US20090233850 CVN-12p1: a recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions
09/17/2009US20090233849 Recombinant Alpha-Fetoprotein, Method and Means for Preparation Thereof, Compositions on the Base Thereof and Use Thereof
09/17/2009US20090233848 Pea15 as a Tumor Suppressor Gene
09/17/2009US20090233846 Human luteinizing hormone superagonists
09/17/2009US20090233840 Modified Dynorphin Expression in Animals and Identification of Compounds for Treatment of Obesity and Diabetes
09/17/2009US20090233812 Target recognizing binding agents
09/17/2009US20090233808 Compounds displayed on replicable genetic packages and methods of using same
09/17/2009US20090233807 Assays that use the t1r1 receptor polypeptides to screen for t1r1-associated taste modulators
09/17/2009US20090233803 Chromogenic in situ hybridization methods, kits, and compositions
09/17/2009US20090233801 Microstructures and use thereof for the directed evolution of biomolecules
09/17/2009US20090233379 Taste Receptors Of The T1R Family From Domestic Dog
09/17/2009US20090233368 Allele suppression
09/17/2009US20090233367 Method of Transferring Substance Into Cell
09/17/2009US20090233366 Composition for introduction of nucleic acid
09/17/2009US20090233365 Arginine-conjugated bioreducible poly(disulfide amine) polymers for gene delivery systems
09/17/2009US20090233364 Method to Engineer MAPK Signaling Responses Using Synthetic Scaffold Interactions and Scaffold-Mediated Feedback Loops
09/17/2009US20090233359 Polymers and complexes for delivery of nucleic acids to intracellular targets
09/17/2009US20090233352 Method on Clinical Applications in Head Neck Cancer by Using DSG3 Molecule for Predicting Malignant Degree of Cancer, Serving as a Molecular Target and Using RNA Jamming Sequence on Inhibition-Specific of DSG3 Expression
09/17/2009US20090233347 Production of polyunsaturated fatty acids in oleaginous yeasts
09/17/2009US20090233346 Production of polyunsaturated fatty acids in oleaginous yeasts
09/17/2009US20090233343 Affinity purification of protein
09/17/2009US20090233335 Variant humicola Grisea CBH1.1
09/17/2009US20090233333 Methods for preventing gluconoylation of proteins
09/17/2009US20090233320 from plankton Metridia pacifica; blue luminescence
09/17/2009US20090233317 Repressor of skeletal muscle differentiation, nucleic acids coding therefor and the use thereof in diagnosis and therapy
09/17/2009US20090233314 Functional domain and associated molecule of dock2 essentially required in lymphocyte migration
09/17/2009US20090233311 receptor binding assay; analysis and determining the level of procalcitonin in blood wherein an increased level of procalcitonin compared to healthy individuals is indicative of sepsis
09/17/2009US20090233296 Thiamin production by fermentation
09/17/2009US20090233290 Mutant SepRS, and method for site-specific introduction of phosphoserine into protein using the same
09/17/2009US20090233288 Primer set for gene amplification, reagent for gene amplification including the same, and uses thereof
09/17/2009US20090233283 Stable compositions for nucleic acid amplification and sequencing
09/17/2009US20090233282 Probe, probe set, probe carrier, and testing method
09/17/2009US20090233278 Branched-chain amino acid aminotransferase gene and use thereof
09/17/2009US20090233274 Drug development target protein and target gene, and method of screening
09/17/2009US20090233272 Multiplexed Nucleic Acid Analysis with High Specificity
09/17/2009US20090232957 Soybean Cultivar 7013345
09/17/2009US20090232956 Soybean Cultivar 7549450
09/17/2009US20090232955 Soybean Cultivar 7317090
09/17/2009US20090232936 Novel lipases and uses thereof
09/17/2009US20090232847 Immunogenic compositions
09/17/2009US20090232842 HPV Vaccine Comprising Peptides From Host Cell Proteins
09/17/2009US20090232837 Anti tumoral immunogenic peptides and vaccine thereof
09/17/2009US20090232830 Modified HIV-1 Envelope Proteins
09/17/2009US20090232826 Antibody or a fragment thereof, having neutralizing activity against hiv but not against il2
09/17/2009US20090232825 Methods and Compositions For Modulating Immunity
09/17/2009US20090232823 Anti-tyrp1 antibodies
09/17/2009US20090232821 Use Of A Growth-Stimulating Protein
09/17/2009US20090232820 Neisseria meningitidis antigens and compositions
09/17/2009US20090232817 Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
09/17/2009US20090232816 Il-1 eta dna and polypeptides
09/17/2009US20090232812 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom
09/17/2009US20090232809 Type 2 cytokine receptor and nucleic acids encoding same
09/17/2009US20090232808 Molecules and chimeric molecules thereof
09/17/2009US20090232804 Humanized antibodies specific for von willebrand factor
09/17/2009US20090232803 Antibodies to human il-1beta
09/17/2009US20090232802 Compositions and methods for the treatment of natural killer cell related diseases
09/17/2009US20090232801 Humanized Antibodies Which Bind To AB (1-42) Globulomer And Uses Thereof
09/17/2009US20090232800 E1-minus adenoviruses and use thereof
09/17/2009US20090232797 Plasmodium malariae and plasmodium ovale genes and uses thereof
09/17/2009US20090232795 1b20 pcsk9 antagonists
09/17/2009US20090232788 Enzyme With Microbial Lysis Activity From Trichoderma Reesei
09/17/2009US20090232762 Compositions for delivery of therapeutic agents
09/17/2009US20090232738 Methods for modulating de novo hepatic lipogenesis by modulating XBP-1 activity
09/17/2009US20090232736 Dual specificity antibodies and methods of making and using
09/17/2009US20090232734 Anti-tissue factor antibodies and compositions
09/17/2009DE10350474C5 Verfahren zur Selektion von Biomolekülen aus Varianten-Bibliotheken von Biomolekülen A method of selecting variants of biomolecules from libraries of biomolecules
09/17/2009DE102008014880A1 Use of a polypeptide with the activity of repulsive guidance molecule A as an antiinflammatory agent
09/17/2009DE102008014041A1 Verfahren zur Erzeugung einer Breitband-Resistenz gegenüber Pilzen in transgenen Pflanzen Method for creating broad-spectrum resistance to fungi in transgenic plants
09/17/2009DE102008013304A1 Expressing a heterologous gene comprises inserting a target gene into an expression vector and transforming a Rhodobacter capsulatus strain with the vector
09/17/2009CA2722479A1 Rna-selective hybridization reagent and use of the same
09/17/2009CA2718499A1 Antibody against the csf-1 r
09/17/2009CA2718495A1 Recombinant production of authentic human proteins using human cell expression systems
09/17/2009CA2718419A1 Hairless immunodeficient mouse model
1 ... 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 ... 4023